Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
暂无分享，去创建一个
M. Mouret-Reynier | N. Colombo | A. Floquet | E. Pujade-Lauraine | A. Hardy-Bessard | A. El-Balat | C. Cropet | T. Nøttrup | Antonio González-Martín | G. Scambia | I. Vergote | E. M. Guerra Alía | Gerhard Bogner | Ingo B. Runnebaum | I. Ray-Coquard | Philipp Harter | S. Pignata | Keiichi Fujiwara | Michel Fabbro | Barbara Schmalfeldt